Darius Kharabi
Corporate Officer/Principal en KALA BIO, INC. .
Fortuna: 90 667 $ al 30/04/2024
Cargos activos de Darius Kharabi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KALA BIO, INC. | Corporate Officer/Principal | 15/11/2021 | - |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Director/Miembro de la Junta | 01/11/2017 | - |
| Presidente | 01/10/2015 | 01/11/2017 | |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Director Ejecutivo | 01/08/2019 | - |
| Director Financiero/CFO | 01/08/2019 | - | |
| Secretario Corporativo | 01/08/2019 | - | |
| Director de Operaciones | 01/10/2015 | 01/08/2019 | |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Fundador | - | - |
Historial de carrera de Darius Kharabi
Antiguos cargos conocidos de Darius Kharabi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Director Ejecutivo | 01/08/2018 | 01/12/2021 |
| Director Financiero/CFO | 01/08/2018 | 01/12/2021 | |
| Presidente | 01/08/2018 | 01/12/2021 | |
OrthAlign Corp.
 OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Corporate Officer/Principal | 01/06/2009 | - |
Formación de Darius Kharabi.
| Stanford University | Graduate Degree |
| Georgetown University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Corporate Officer/Principal | 2 |
| President | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
OrthAlign Corp.
OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Health Technology |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Combangio, Inc.
Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Darius Kharabi
- Experiencia
